alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.14


    CONVERTIBLE
      DEMAND PROMISSORY NOTE

     

    
      	
              $93,000.00

              
                March
                  3, 2006

              

            


    

     

    FOR
      VALUE
      RECEIVED, the undersigned Language Access Network, Inc.. ("Payor"), promises
      to
      pay to the order of Patios Industries, LLC. ("Holder"), on demand, at such
      address as may be designated in writing by Holder of this Note, the principal
      amount of Ninty Three Thousand Dollars ($93,000.00) together with interest
      on
      the unpaid principal amount from March 3, 2006, at the rate of ten percent
      (10%)
      per annum.

     

    $44,000,000.00
      January 27, 2006

    $10,000,000.00
      - February 10, 2006

    $15,000,000.00
      -February 16, 2006

    $24,000,000.00
      -- March 1, 2006

    


    All
      payments of principal, interest or other amounts payable on or in respect of
      this Note shall be made in lawful currency of the United States of America
      in
      immediately available funds, to the Holder, unless otherwise directed in writing
      by Holder.

    


    Holder
      of
      this note may, at his option and at any time prior to payment in full of any
      outstanding principal and interest payments on this Note, convert all or any
      portion of the Note to equity of Payor at $0.25 per share of Payor's Common
      Stock.

    


    Any
      waiver of any payment due hereunder or the acceptance by the Holder of partial
      payments hereunder shall not, at any other time, be taken to be a waiver of
      the
      terms of this Note or any other agreement between the Payor and the
      Holder.

    


    Presentment
      for payment, notice of dishonor, protest and notice of protest are hereby
      waived.

     

    This
      Note
      shall be governed by and interpreted in accordance with the laws of the State
      of
      Nevada.

     

    IN
      WITNESS WHEREOF, the undersigned has executed this Note as of the date first
      written above.

    
      
         

        
          	Language Access Network, Inc.
	
                  By: /s/ Andrew Panos

                         Andrew
                    Panos

                
	Its: 
PRESIDENT
Fourth Court of Appeals

San Antonio, Texas

August 11, 2021

No. 04-21-00273-CR

The STATE of Texas,

Appellant

v.

Marco Antonio GLORIA,

Appellee

From the 365th Judicial District Court, Maverick County, Texas

Trial Court No. 19-02-07982-MCRAJA

Honorable Amado J. Abascal, III, Judge Presiding

O R D E R

On August 10, 2021, appellee filed a Motion to Substitute Appellate Counsel. After 

consideration, appellee’s motion is GRANTED. We ORDER the clerk of this court to update 

the records of this case to show Clay Dean Thomas as attorney of record for appellee.

_________________________________

Beth Watkins, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 11th day of August, 2021.

___________________________________

MICHAEL A. CRUZ, Clerk of Court

FILE COPY
13 CCR s 2262.2

Cal. Admin. Code tit. 13 , s 2262 .2

BARCLAYS OFFICIAL CALIFORNIA CODE OF REGULATIONS

TITLE 13. MOTOR VEHICLES DIVISION 3. AIR RESOURCES BOARD CHAPTER 5. STANDARDS FOR MOTOR VEHICLE FUELS ARTICLE 1. STANDARDS FOR GASOLINE SUBARTICLE 2. STANDARDS FOR GASOLINE SOLD BEGINNING MARCH 1, 1996

This database is current through 12/26/2003, Register 2003, No. 52. s 2262.2. Standards for Sulfur Content. <General Materials (GM) - References, Annotations, or Tables> Note: Authority cited: Sections 39600, 39601 , 43013 , 43018 and 43101, Health and Safety Code ; and Western Oil and Gas Ass'n. v. Orange County Air Pollution Control District, 14 Cal.3d 411, 121 Cal. Rptr. 249 (1975)

. Reference: Sections 39000, 39001 , 39002 , 39003 , 39010, 39500, 39515 , 39516 , 41511 , 43000, 43016 , 43018 and 43101, Health and Safety Code ; and Western Oil and Gas Ass'n. v. Orange County Air Pollution Control District, 14 Cal.3d 411, 121 Cal. Rptr. 249 (1975)

. HISTORY 1. New section filed 11-16-92; operative 12-16-92 (Register 92, No. 47). 2. Amendment of subsections (b)-(c) and repealer of subsection (d) filed 6-2-95; operative 7-3-95 (Register 95, No. 22). 3. Amendment filed 9-21-98; operative 9-21-98 pursuant to Government Code section 11343.4(d) (Register 98, No. 39). 4. Repealer filed 8-3-2000; operative 9-2-2000 (Register 2000, No. 31).
13 CA ADC s 2262.2
END OF DOCUMENT Page 1

© 2010 Thomson Reuters. No Claim to Orig. US Gov. Works.
EXHIBIT 21



                      SUBSIDIARIES OF AZTAR CORPORATION

The Company has no parent corporation.  In addition to the subsidiaries listed
below, the Company has eight other wholly-owned subsidiaries.  The unnamed
subsidiaries, considered in the aggregate, would not constitute a significant
subsidiary.

                                                           Jurisdiction of
                                                            Incorporation 
            Name                                           or Organization
            ----                                           ---------------

Adamar Garage Corporation                                     Delaware

Adamar of Nevada                                              Nevada

Adamar of New Jersey, Inc.                                    New Jersey
     dba Tropicana Casino and Resort

Atlantic-Deauville, Inc.                                      New Jersey

Aztar Development Corporation                                 Delaware

Aztar Indiana Gaming Corporation                              Indiana

Aztar Missouri Gaming Corporation                             Missouri

Hotel Ramada of Nevada                                        Nevada
     dba Tropicana Resort and Casino

Ramada Express, Inc.                                          Nevada
     dba Ramada Express Hotel and Casino

Ramada New Jersey, Inc.                                       New Jersey

Ramada New Jersey Holdings Corporation                        Delaware
```

[Federal Register: June 25, 2010 (Volume 75, Number 122)]
[Notices]               
[Page 36471-36472]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25jn10-118]                         

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

 
Seventh Meeting--RTCA Special Committee 220: Automatic Flight 
Guidance and Control

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of RTCA Special Committee 220: Automatic Flight Guidance 
and Control meeting.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of a 
meeting of RTCA Special Committee 220: Automatic Flight Guidance and 
Control.

DATES: The meeting will be held July 13-15, 2010. July 13th and 14th 
from 9 a.m. to 5 p.m. and July 15th from 9 a.m. to 2 p.m.

ADDRESSES: The meeting will be held at the Bourbon Orleans Hotel, 717 
Orleans Street, New Orleans, LA 70116, Phone: 504-571-4687, Fax: 504-
525-8166, E-Mail: http://www.bourbonorleans.com.

FOR FURTHER INFORMATION CONTACT: (1) RTCA Secretariat, 1828 L Street, 
NW., Suite 805, Washington, DC, 20036; telephone (202) 833-9339; fax 
(202) 833-9434; Web site http://www.rtca.org.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal 
Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., Appendix 2), notice 
is hereby given for a Special Committee 220: Automatic Flight Guidance 
and

[[Page 36472]]

Control meeting. The agenda will include:
     Welcome/Agenda Overview.
     Consider for Approval--New Document--Minimum Operational 
Performance Standards (MOPS) for Automatic Flight Guidance and Control 
Systems and Equipment, RTCA Paper No. 088-10/SC220-042.
     Continue Development of Installation Guidance White 
Papers.
     Wrap-up and Review of Action Items.
     Establish Dates, Location, Agenda for Next Meeting, Other 
Business.
    Attendance is open to the interested public but limited to space 
availability. With the approval of the chairmen, members of the public 
may present oral statements at the meeting. Persons wishing to present 
statements or obtain information should contact the person listed in 
the FOR FURTHER INFORMATION CONTACT section. Members of the public may 
present a written statement to the committee at any time.

    Issued in Washington, DC, on June 17, 2010.
Meredith Gibbs,
RTCA Advisory Committee.
[FR Doc. 2010-15430 Filed 6-24-10; 8:45 am]
BILLING CODE 4910-13-P
```
```

                                                                    Exhibit 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER

  Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss.1350)

Pursuant to Section 906 of the Sarbanes-Oxley  Act of 2002 (18 U.S.C.  ss.1350),
the undersigned, Michael E. DeDomenico, Chief Executive Officer of NuCO2 Inc., a
Florida  corporation  (the  "Company"),  does hereby certify,  to his knowledge,
that:

The Report on Form 10-K/A for the fiscal year ended June 30, 2005 of the Company
(the "Report") fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934, and the information contained in the Report
fairly presents,  in all material respects,  the financial condition and results
of operations of the Company.

                                             /s/ Michael E. DeDomenico
                                             -------------------------
                                             Michael E. DeDomenico
                                             Chief Executive Officer
                                             February 22, 2006
```
"Marashi, Fred" <MARASF@cpchem.com> 02/03/2010 03:47 PM To EHPV-Program-Submissions@EPA
cc Jeffrey Taylor/DC/USEPA/US@EPA, "'Franz, Christina'" <Christina

_ Franz@americanchemistry.com>, "Arrieta, Daniel E" <ARRIEDE@cpchem.com> bcc Subject Revised Robust Summary and Test Plan for Ethanol, 2-Octylthio- (CAS# 3547-33-9) Dear EHPV Group, Chevron Phillips Chemical Company LP submits the attached revised sanitized version of the robust summary and test plan for Ethanol, 2-Octylthio- (CAS# 3547-33-9) under the EHPV program for public documentation. Confidential and sanitized versions of this revised robust summary and test plan submission have been submitted to EPA's Document Control Office (DCO).
Best Regards, Fred Marashi, Ph.D. Senior Regulatory Compliance Advisor Product Safety Group Chevron Phillips Chemical Company LP 10001 Six Pines Drive; Suite 4104 The Woodlands, TX 77380 Tel: 832-813-4675; Fax: 832-814-4435 This message is conveyed, and any usage is expressly subject to the disclaimer found at the following link: http://www.cpchem.com/forms/disclaimer1.asp

- Revised eHPV ethanol2-(octylthio)

_ FINAL

_ SANITIZED.PDF
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               SEP-30-1998
<CASH>                                         $24,720
<SECURITIES>                                         0
<RECEIVABLES>                                   12,987
<ALLOWANCES>                                     1,265
<INVENTORY>                                      2,480
<CURRENT-ASSETS>                                47,920
<PP&E>                                          76,352
<DEPRECIATION>                                  32,621
<TOTAL-ASSETS>                                  97,432
<CURRENT-LIABILITIES>                           16,914
<BONDS>                                         22,363
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           217
<OTHER-SE>                                      54,828
<TOTAL-LIABILITY-AND-EQUITY>                    97,432
<SALES>                                         99,405
<TOTAL-REVENUES>                                99,405
<CGS>                                           70,503
<TOTAL-COSTS>                                   70,503
<OTHER-EXPENSES>                                37,053
<LOSS-PROVISION>                                   498
<INTEREST-EXPENSE>                               2,437
<INCOME-PRETAX>                               (10,588)
<INCOME-TAX>                                     (978)
<INCOME-CONTINUING>                            (9,610)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,610)
<EPS-PRIMARY>                                   (0.45)
<EPS-DILUTED>                                   (0.45)
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM NUCO2 INC.
FINANCIAL  STATEMENTS  AS OF JUNE 30, 1999 AND IS  QUALIFIED  IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                              <C>
<PERIOD-TYPE>                    12-MOS
<FISCAL-YEAR-END>                                 JUN-30-1999
<PERIOD-END>                                      JUN-30-1999
<CASH>                                              1,579,191
<SECURITIES>                                                0
<RECEIVABLES>                                       7,325,308
<ALLOWANCES>                                          557,592
<INVENTORY>                                           213,605
<CURRENT-ASSETS>                                    9,153,999
<PP&E>                                            120,227,912
<DEPRECIATION>                                     20,563,022
<TOTAL-ASSETS>                                    141,630,201
<CURRENT-LIABILITIES>                               9,609,272
<BONDS>                                                     0
<PREFERRED-MANDATORY>                                       0
<PREFERRED>                                                 0
<COMMON>                                                7,217
<OTHER-SE>                                         47,725,464
<TOTAL-LIABILITY-AND-EQUITY>                      141,630,201
<SALES>                                            47,097,670
<TOTAL-REVENUES>                                   47,097,670
<CGS>                                              25,224,746
<TOTAL-COSTS>                                      48,541,599
<OTHER-EXPENSES>                                            0
<LOSS-PROVISION>                                            0
<INTEREST-EXPENSE>                                  7,524,966
<INCOME-PRETAX>                                    (8,932,940)
<INCOME-TAX>                                                0
<INCOME-CONTINUING>                                (8,932,940)
<DISCONTINUED>                                              0
<EXTRAORDINARY>                                             0
<CHANGES>                                                   0
<NET-INCOME>                                       (8,932,940)
<EPS-BASIC>                                           (1.24)
<EPS-DILUTED>                                           (1.24)


</TABLE>
Exhibit 10.1










Exhibit 10.1


 


April 26, 2010



Michael G. Kaplitt, M.D., Ph.D.


Department of Neurosurgery


Weill Medical College of Cornell University


525 E. 68th Street


New York, NY 10021



Dear Dr. Kaplitt:



This letter (the “Amendment”) amends that certain Amended and Restated Consulting Agreement, dated as of April 25,
2005, by and between you and Neurologix Research, Inc., the predecessor by merger to Neurologix, Inc. (the “Company”),
the terms of which were subsequently amended by resolution of the Company’s Board of Directors on September 14, 2006 to
increase the annual compensation payable thereunder to $175,000. References in this Amendment to the “Consulting
Agreement” set forth in this Amendment shall mean the Amended and Restated Consulting Agreement, as amended in
September, 2006. Capitalized terms used herein, but not otherwise defined, shall have the meanings set forth in the
Consulting Agreement.



For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, it is agreed as
follows:




	 	1.	 	Section 4 of the Consulting Agreement is hereby amended and restated to read as follows:






4. Term. The term of this Agreement shall commence on the Effective Date and shall continue
until April 30, 2011.




	 	2.	 	Except as amended by this Amendment, all of your and the Company’s respective rights and
obligations under the Consulting Agreement and the related Confidentiality, Proprietary Information and
Inventions Agreement, dated as of October 1, 1999, between you and Neurologix Research, Inc., shall be
deemed preserved by this Amendment, without modification or reduction. After the date of this Amendment
any reference to the Consulting Agreement shall mean the Consulting Agreement as further modified and
amended hereby.







	 	3.	 	This Amendment shall be governed by, and construed pursuant to, the laws of the State of New York
applicable to agreements made and to be performed wholly within such State.







	 	4.	 	This Amendment may be executed in one or more counterparts, each of which shall be deemed to
be an original but all of which together shall constitute one and the same instrument. This Amendment may
be executed by the delivery of facsimile or pdf copies of the signatures of the parties hereto.






[Signature Page Follows]






 


4









 









IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first written above.



Very truly yours,



NEUROLOGIX, INC.



By:  /s/ Clark A. Johnson                              

Clark A. Johnson

President and Chief Executive Officer




By:  /s/ Marc Panoff                                     

Marc Panoff

Chief Financial Officer, Secretary and Treasurer




ACCEPTED AND AGREED:



/s/ Michael G. Kaplitt                                   

Michael G. Kaplitt, M.D., Ph.D.


 


5
Exhibit
32.1




CERTIFICATION




Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002




(Subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States
Code)




Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code), each of the
undersigned officers of Platinum Energy Resources, Inc., a Delaware corporation
(the “Company”), does hereby certify, to such officer’s knowledge,
that:




The
Quarterly Report on Form 10-Q for the quarter ended March 31,
2009 (the “Form 10-Q”) of the Company fully complies with the requirements
of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
information contained in the Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of the
Company.




Date: July
      1, 2009
              
              /s/ Al
      RahmaniAl
      RahmaniInterimChief Executive OfficerDate: July
      1, 2009
              
              /s/
      Michael CunninghamMichael
      Cunningham
                InterimChief Financial
Officer




A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-6731

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

THEODORE HOWZE,

Defendant - Appellant.

Appeal from the United States District Court for the Western District of North Carolina, at Charlotte. Robert D. Potter, Senior

District Judge. (CR-92-30-P, CA-95-432-3-P)

Submitted: October 3, 1996 Decided: October 15, 1996

Before ERVIN, LUTTIG, and MICHAEL, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Theodore Howze, Appellant Pro Se. Kenneth Davis Bell, OFFICE

OF THE UNITED STATES ATTORNEY, Charlotte, North Carolina, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals from the district court's order denying his

28 U.S.C. § 2255 (1994), amended by Antiterrorism and Effective

Death Penalty Act of 1996, Pub. L. No. 104-132, 110 Stat. 1214,

motion. We have reviewed the record and the district court's opinion and find no reversible error. Accordingly, we affirm on the

reasoning of the district court. United States v. Howze, Nos. CR92-30-P; CA-95-432-3-P (W.D.N.C. Mar. 14, 1996). We dispense with

oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would

not aid the decisional process.

AFFIRMED
Good afternoon Pyrethroid Registrants,

This email is to inform you that EPA has developed a pyrethroid registration review risk assessment strategy that will assess the pyrethroids as a class with regard to ecological risks, rather than conducting assessments by individual chemical. The toxicity of pyrethroids to aquatic organisms is well established, and expected to drive the risk conclusions; therefore the single, streamlined assessment will focus on the risks to aquatic organisms. Measures to mitigate this risk will be considered early in the development of the assessment. The Agency would like to explore potential mitigation measures with pyrethroid registrants as soon as possible, beginning in early 2015. This approach is intended to increase efficiency and consistency, and to clarify where the risks are focused in order to develop meaningful mitigation as a class.

The assessment will also initially focus on the pyrethroids for which the Pyreth roid Working Group (PWG) has conducted multiple studies and for which there is ample monitoring data: bifenthrin, cypermethrin, cyfluthrins, deltamethrin, esfenvalerate, fenpropathrin, cyhalothrin, and permethrin, with the addition of the pyrethrins. With refinements, this approach is intended to cover all of the pyrethroids currently undergoing registration review. The assessment will be organized according to the use categories of agricultural, outdoor residential, indoor down

- the

- drain, and wide area mos quito adulticide uses. This will be a FIFRA assessment only, and will not include potential risks under the Endangered Species Act (ESA) or to pollinators, which will be addressed at a later date. To that end, toxicity data called in under registration rev iew will still be reviewed and incorporated into the assessment wherever possible; however, data that have not yet been received and reviewed for completion of the FIFRA assessment will be considered in the endangered species assessment.

The pyrethroid r egistration review human health risk assessments will be conducted for the individual chemicals; a single streamlined assessment for human health is not under consideration. This is because there are different endpoints for the individual pyrethroids for
h uman health, based on the most sensitive toxicity endpoint across all studies, versus the neurotoxicity mode of action for the cumulative assessment.

The anticipated date for publication of the draft ecological risk assessment, and the
individual human he alth assessments, is September 2016. I will be coordinating the pyrethroid risk assessment effort across the Office of Pesticide Programs; if you have any questions, please contact me by email or call me at 703

- 308

- 8049.

Sincerely,

Garland Waleko Chemical Review Manager (RMIB2)
Pesticide Re

- evaluation Division (PRD)

, Office of Pesticide Programs (OPP) U.S. Environmental Protection Agency (703) 308

- 8049 ; waleko.garland@epa.gov